Follow The Filings

TBI Trueblue Inc.

Consumer Discretionary, filed as TRUEBLUE INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $22M
  • 1 add

In 2026 Q2 Richard Pzena added to Trueblue.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena Add 0.06%

Who owns TBI

Sorted by value, long equity only, as of 2026 Q2.

History
Richard Pzena, Pzena Investment Management 0.06%, was 0.03% Add +7.6% 3,090,808 $22M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by TBI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TBI insider trades
  • $149K bought by 3 insiders
  • $15K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Sonita Lontoh Director
    Sale
    $15K 2,186 shares at $6.73 2.9% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  2. Garrett Ferencz EVP, Chief Legal Officer
    Buy
    $25K 7,000 shares at $3.61 +3.1% to stake
    Traded Feb 25 Filed Feb 26
    ↗
  3. Taryn R Owen CEO
    Buy
    $77K 20,400 shares at $3.79 +2.6% to stake
    Traded Feb 24 Filed Feb 26
    ↗
  4. Carl Schweihs CFO
    Buy
    $47K 12,500 shares at $3.72 +4.5% to stake
    Traded Feb 23 Filed Feb 24
    ↗

Also filed in the last 12 months, not counted as buying or selling: 20 share withholdings for taxes and 14 stock grants.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q TRUEBLUE FORM 10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,3.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q TRUEBLUE FORM 10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.91B $1.57B $1.62B
Gross profit $506.06M $406.39M $367.84M
Gross margin * 26.5% 25.9% 22.8%
Net income -$14.17M -$125.75M -$47.96M
Net margin * -0.7% -8.0% -3.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $354.99M $277.09M $297.61M
Total non-current assets * $544.39M $398.28M $341.06M
Total assets $899.38M $675.38M $638.67M
Total current liabilities $204.1M $160.12M $138.53M
Total non-current liabilities * $237.41M $199.89M $225.58M
Total equity $457.87M $315.36M $274.56M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $34.75M -$17.06M -$58.04M
Cash from investing -$32.32M -$2.45M -$16.06M
Cash from financing -$37.58M -$17.09M $57.14M
Net change in cash -$36.32M -$38.21M -$17.08M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.